Es gab 50 kürzliche Insider-Transaktionen für Rezolute, Inc. (RZLT), darunter 45 Käufe und 3 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $10.56M und die gesamten Insider-Verkäufe auf $150.98K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Evans Daron, Elam Nevan C, Roberts Brian Kenneth. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — RZLT
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-30 |
Evans Daron |
CFO |
Informierter Kauf |
10,000 |
$2.85 |
$28.5K |
414,462 |
| 2026-03-02 |
Elam Nevan C |
CEO |
RSU-Steuereinbehalt |
27,618 |
$2.99 |
$82.58K |
613,501 |
| 2026-03-02 |
Evans Daron |
CFO |
RSU-Steuereinbehalt |
11,438 |
$2.99 |
$34.2K |
404,462 |
| 2026-03-02 |
Roberts Brian Kenneth |
Chief Medical Officer |
RSU-Steuereinbehalt |
11,439 |
$2.99 |
$34.2K |
296,913 |
| 2025-12-16 |
Hogenhuis Wladimir |
Director |
Informierter Kauf |
5,650 |
$1.69 |
$9.55K |
119,675 |
| 2025-12-16 |
Roberts Brian Kenneth |
Chief Medical Officer |
Informierter Kauf |
28,000 |
$1.70 |
$47.6K |
308,352 |
| 2025-12-15 |
Elam Nevan C |
CEO |
Informierter Kauf |
32,000 |
$1.59 |
$50.88K |
641,119 |
| 2025-12-15 |
Evans Daron |
CFO |
Informierter Kauf |
2,500 |
$1.79 |
$4.46K |
7,000 |
| 2025-12-15 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
Informierter Kauf |
12,000 |
$1.62 |
$19.44K |
71,442 |
| 2025-12-09 |
Evans Daron |
CFO |
Informierter Kauf |
10,549 |
$5.04 |
$53.17K |
131,900 |
| 2025-11-19 |
Elam Nevan C |
CEO |
RSU-Zuteilung |
186,000 |
$10.16 |
$1.89M |
186,000 |
| 2025-11-19 |
Labrucherie Gil M |
Director |
RSU-Zuteilung |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Evans Daron |
CFO |
RSU-Zuteilung |
63,000 |
$10.16 |
$640.08K |
63,000 |
| 2025-11-19 |
Kreher Nerissa |
Director |
RSU-Zuteilung |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Hogenhuis Wladimir |
Director |
RSU-Zuteilung |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Kim Young-jin |
Director |
RSU-Zuteilung |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Harris Erik |
Director |
RSU-Zuteilung |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Fauchet Philippe |
Director |
RSU-Zuteilung |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Roberts Brian Kenneth |
Chief Medical Officer |
Erwerb |
72,000 |
$10.16 |
$731.52K |
72,000 |
| 2025-11-19 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
RSU-Zuteilung |
19,000 |
$10.16 |
$193.04K |
19,000 |
| 2025-08-18 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
Unbekannt |
- |
- |
- |
1,898 |
| 2025-08-18 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
RSU-Zuteilung |
25,000 |
- |
- |
27,442 |
| 2025-06-25 |
Roberts Brian Kenneth |
Chief Medical Officer |
Informierter Kauf |
2,500 |
$4.38 |
$10.94K |
15,500 |
| 2025-06-24 |
Evans Daron |
CFO |
Informierter Kauf |
5,000 |
$4.05 |
$20.25K |
268,900 |
| 2025-06-13 |
Kreher Nerissa |
Director |
Informierter Kauf |
3,076 |
$3.25 |
$10K |
37,576 |
| 2025-06-13 |
Kim Young-jin |
Director |
Informierter Kauf |
1,230,769 |
$3.25 |
$4M |
8,423,386 |
| 2025-06-10 |
Elam Nevan C |
CEO |
RSU-Zuteilung |
40,000 |
$4.39 |
$175.6K |
40,000 |
| 2025-06-10 |
Evans Daron |
CFO |
RSU-Zuteilung |
15,000 |
$4.39 |
$65.85K |
15,000 |
| 2025-06-10 |
Kim Young-jin |
Director |
RSU-Zuteilung |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-06-10 |
Fauchet Philippe |
Director |
RSU-Zuteilung |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-06-10 |
Roberts Brian Kenneth |
Chief Medical Officer |
RSU-Zuteilung |
15,000 |
$4.39 |
$65.85K |
15,000 |
| 2025-06-10 |
Labrucherie Gil M |
Director |
RSU-Zuteilung |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-06-10 |
Kreher Nerissa |
Director |
RSU-Zuteilung |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-06-10 |
Hogenhuis Wladimir |
Director |
RSU-Zuteilung |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-03-31 |
Hogenhuis Wladimir |
Director |
Informierter Kauf |
6,758 |
$2.92 |
$19.73K |
84,025 |
| 2025-03-27 |
Elam Nevan C |
CEO |
Informierter Kauf |
12,302 |
$2.85 |
$35K |
224,119 |
| 2025-03-26 |
Evans Daron |
CFO |
Informierter Kauf |
10,000 |
$2.88 |
$28.8K |
23,000 |
| 2025-03-25 |
Harris Erik |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-03-25 |
Harris Erik |
Director |
RSU-Zuteilung |
60,000 |
$2.89 |
$173.4K |
60,000 |
| 2025-02-18 |
Hogenhuis Wladimir |
Director |
Informierter Kauf |
10,000 |
$4.70 |
$47K |
77,267 |
| 2025-02-16 |
Elam Nevan C |
CEO |
RSU-Zuteilung |
120,000 |
$4.61 |
$553.2K |
120,000 |
| 2025-02-16 |
Evans Daron |
CFO |
RSU-Zuteilung |
45,000 |
$4.61 |
$207.45K |
45,000 |
| 2025-02-16 |
Kreher Nerissa |
Director |
RSU-Zuteilung |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2025-02-16 |
Kim Young-jin |
Director |
RSU-Zuteilung |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2025-02-16 |
Fauchet Philippe |
Director |
RSU-Zuteilung |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2025-02-16 |
Roberts Brian Kenneth |
Chief Medical Officer |
RSU-Zuteilung |
45,000 |
$4.61 |
$207.45K |
45,000 |
| 2025-02-16 |
Labrucherie Gil M |
Director |
RSU-Zuteilung |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2025-02-16 |
Hogenhuis Wladimir |
Director |
RSU-Zuteilung |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2024-12-18 |
Evans Daron |
CFO |
Informierter Kauf |
10,000 |
$4.29 |
$42.9K |
150,900 |
| 2024-12-12 |
Evans Daron |
CFO |
Informierter Kauf |
9,000 |
$4.60 |
$41.4K |
140,900 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
